Buffalo Business First featured Lippes Mathias health care partner Brigid Maloney in an article examining the regulatory gaps affecting cash-only telehealth platforms prescribing compounded GLP-1 medications and peptides. Maloney highlighted that without HIPAA oversight or insurance compliance requirements, particularly at large national telehealth companies, patient data protections are significantly weaker and incomplete medical records can create dangerous drug interaction risks.